Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men with Normal to Moderately Elevated Serum Cholesterol Levels. The Regression Growth Evaluation Statin Study (REGRESS) - REGRESS


REGRESS was a double-blind, placebo-controlled multicenter study that assessed the effects of pravastatin on progression and regression of coronary atherosclerosis in 885 men with known coronary artery disease (CAD) and normal to moderately elevated serum cholesterol levels